Angina Pectoris – Epidemiology Forecast to 2028

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Angina pectoris is a chest pain or discomfort often described as squeezing, pressure, heaviness, or tightness in the chest and is caused by reduced blood flow to the heart (Mayo Clinic, 2020). The reduced blood flow occurs when arteries that carry blood to the heart become narrowed and blocked because of a blood clot or atherosclerosis (Johns Hopkins Medicine, 2020). The reduced blood flow can also occur because of unstable plaques, poor blood flow through a narrowed heart valve, a decreased pumping function of the heart muscle, as well as a coronary artery spasm (Johns Hopkins Medicine, 2020; Mayo Clinic, 2020). Angina can be classified as stable angina, unstable angina, Prinzmetal angina, and microvascular angina based on the above-mentioned causes (The Society for Cardiovascular Angiography and Interventions, 2014; Mayo Clinic, 2020).
In 2018, there were 1,128,150 diagnosed incident cases of angina pectoris in men and women combined, age 18 years and older, in the 7MM. The US accounted for the majority of these cases with 801,516 diagnosed incident cases, while Spain accounted for the fewest cases with 36,820 cases in 2018. GlobalData epidemiologists forecast an increase in the diagnosed incident cases of angina pectoris to 1,292,695 cases in 2028 in the 7MM at an Annual Growth Rate (AGR) of 1.46% during the forecast period.
In 2018, there were 19,584,590 diagnosed prevalent cases of angina pectoris in men and women combined, age 18 years and older, in the 7MM. The US accounted for the majority of these cases with 5,527,282 cases, while Japan accounted for the fewest cases with 465,983 cases in 2018. The diagnosed prevalent cases of angina pectoris will increase to 22,797,390 cases in 2028 at an AGR of 1.64% during the forecast period.

Scope

The Angina Pectoris Report and Model provides an overview of the risk factors, comorbidities, and the global and historical trends for angina pectoris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiological forecast for the diagnosed incident cases and the diagnosed prevalent cases of angina pectoris, each segmented into stable angina, unstable angina, Prinzmetal angina, and microvascular angina in those ages 18 years and older. The forecast for the diagnosed incident cases and diagnosed prevalent cases of angina pectoris, Prinzmetal angina, and microvascular angina are segmented by age, and stable angina and unstable angina are segmented by both sex and age. The comorbidities—diabetes, hypertension, chronic obstructive pulmonary disease (COPD), and chronic renal disease—among the diagnosed incident cases and diagnosed prevalent cases of angina pectoris are also provided. Lastly, the report includes diagnosed prevalent cases of refractory angina among diagnosed prevalent cases of angina pectoris.

The angina pectoris epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.

• The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

• The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to Buy

The Angina Pectoris Epidemiology series will allow you to:

Develop business strategies by understanding the trends shaping and driving the global angina pectoris market.

Quantify patient populations in the global angina pectoris market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups that present the best opportunities for angina pectoris therapeutics in each of the markets covered.

Understand magnitude of refractory angina and angina pectoris by types.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Angina Pectoris: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods

3.4.3 Diagnosed Incident Cases of Angina Pectoris

3.4.4 Diagnosed Prevalent Cases of Angina Pectoris

3.4.5 Comorbidities of Diagnosed Incident and Diagnosed Prevalent Cases of Angina Pectoris

3.4.6 Diagnosed Prevalent Cases of Refractory Angina

3.5 Epidemiological Forecast for Angina Pectoris, 2018–2028

3.5.1 Diagnosed Incident Cases of Angina Pectoris

3.5.2 Age-Specific Diagnosed Incident Cases of Angina Pectoris

3.5.3 Diagnosed Incident Cases of Stable Angina

3.5.4 Diagnosed Incident Cases of Unstable Angina

3.5.5 Diagnosed Incident Cases of Prinzmetal Angina

3.5.6 Diagnosed Incident Cases of Microvascular Angina

3.5.7 Diagnosed Incident Cases of Angina Pectoris by Comorbidities

3.5.8 Diagnosed Prevalent Cases of Angina Pectoris

3.5.9 Age-Specific Diagnosed Prevalent Cases of Angina Pectoris

3.5.10 Diagnosed Prevalent Cases of Stable Angina

3.5.11 Diagnosed Prevalent Cases of Unstable Angina

3.5.12 Diagnosed Prevalent Cases of Prinzmetal Angina

3.5.13 Diagnosed Prevalent Cases of Microvascular Angina

3.5.14 Comorbidities of Diagnosed Prevalent Cases of Angina Pectoris

3.5.15 Diagnosed Prevalent Cases of Refractory Angina

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

4.1 Bibliography

4.2 About the Authors

4.2.1 Epidemiologist

4.2.2 Reviewers

4.2.3 Global Director of Therapy Analysis and Epidemiology

4.2.4 Global Head and EVP of Healthcare Operations and Strategy

4.3 About GlobalData

4.4 Contact Us

4.5 Disclaimer

Table

Table 1: Risk Factors and Comorbidities for Angina Pectoris

Figures

Figure 1: 7MM, Diagnosed Incident Cases of Angina Pectoris, Both Sexes, Ages ≥18 Years, 2018 and 2028

Figure 2: 7MM, Diagnosed Prevalent Cases of Angina Pectoris, Both Sexes, Ages ≥18Years, 2018 and 2028

Figure 3: 7MM, Diagnosed Incidence of Angina Pectoris, Both Sexes, Ages ≥18 Years, Cases per 100,000 Population, 2018

Figure 4: 7MM, Diagnosed Prevalence of Angina Pectoris, Both Sexes, Ages ≥18 Years, %, 2018

Figure 5: 7MM, Sources Used to Forecast the Diagnosed Incident Cases of Stable Angina

Figure 6: 7MM, Sources Used to Forecast the Diagnosed Incident Cases and Diagnosed Prevalent Cases of Unstable Angina

Figure 7: 7MM, Sources Used to Forecast the Diagnosed Incident Cases and Diagnosed Prevalent Cases of Prinzmetal Angina

Figure 8: 7MM, Sources Used to Forecast the Diagnosed Incident Cases and Diagnosed Prevalent Cases of Microvascular Angina

Figure 9: 7MM, Sources Used to Forecast the Diagnosed Incident Cases of Angina Pectoris by Comorbidities (Diabetes and Hypertension)

Figure 10: 7MM, Sources Used to Forecast the Diagnosed Incident Cases of Angina Pectoris by Comorbidities (COPD and Chronic Renal Disease)

Figure 11: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of Stable Angina

Figure 12: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of Refractory Angina

Figure 13: 7MM, Diagnosed Incident Cases of Angina Pectoris, Both Sexes, Ages ≥18 Years, N, 2018

Figure 14: 7MM, Diagnosed Incident Cases of Angina Pectoris by Age, Both Sexes, N, 2018

Figure 15: 7MM, Diagnosed Incident Cases of Stable Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 16: 7MM, Diagnosed Incident Cases of Unstable Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 17: 7MM, Diagnosed Incident Cases of Prinzmetal Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 18: 7MM, Diagnosed Incident Cases of Microvascular Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 19: 7MM, Diagnosed Incident Cases of Angina Pectoris by Comorbidities, Both Sexes, Ages ≥18 Years, N, 2018

Figure 20: 7MM, Diagnosed Prevalent Cases of Angina Pectoris, Both Sexes, Ages ≥18 Years, N, 2018

Figure 21: 7MM, Diagnosed Prevalent Cases of Angina Pectoris by Age, Both Sexes, N, 2018

Figure 22: 7MM, Diagnosed Prevalent Cases of Stable Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 23: 7MM, Diagnosed Prevalent Cases of Unstable Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 24: 7MM, Diagnosed Prevalent Cases of Prinzmetal Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 25: 7MM, Diagnosed Prevalent Cases of Microvascular Angina, Both Sexes, Ages ≥18 Years, N, 2018

Figure 26: 7MM, Diagnosed Prevalent Cases of Angina Pectoris by Comorbidities, Both Sexes, Ages ≥18 Years, N, 2018

Figure 27: 7MM, Diagnosed Prevalent Cases of Refractory Angina, Both Sexes, Ages ≥18 Years, N, 2018

Frequently asked questions

Angina Pectoris – Epidemiology Forecast to 2028 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Angina Pectoris – Epidemiology Forecast to 2028 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Angina Pectoris – Epidemiology Forecast to 2028 in real time.

  • Access a live Angina Pectoris – Epidemiology Forecast to 2028 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.